ATE449187T1 - Molekulare eigenschaften von nichtkleinzelligem lungenkrebs - Google Patents

Molekulare eigenschaften von nichtkleinzelligem lungenkrebs

Info

Publication number
ATE449187T1
ATE449187T1 AT02794901T AT02794901T ATE449187T1 AT E449187 T1 ATE449187 T1 AT E449187T1 AT 02794901 T AT02794901 T AT 02794901T AT 02794901 T AT02794901 T AT 02794901T AT E449187 T1 ATE449187 T1 AT E449187T1
Authority
AT
Austria
Prior art keywords
sage
small cell
gene expression
lung cancer
normal
Prior art date
Application number
AT02794901T
Other languages
English (en)
Inventor
Mariana Nacht
Tatiana Dracheva
David Sidransky
Stephen L Madden
Jin Jen
Original Assignee
Us Health
Genzyme Corp
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health, Genzyme Corp, Univ Johns Hopkins filed Critical Us Health
Application granted granted Critical
Publication of ATE449187T1 publication Critical patent/ATE449187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02794901T 2001-08-16 2002-08-16 Molekulare eigenschaften von nichtkleinzelligem lungenkrebs ATE449187T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31240001P 2001-08-16 2001-08-16
PCT/US2002/026027 WO2003015613A2 (en) 2001-08-16 2002-08-16 Molecular characteristics of non-small cell lung cancer

Publications (1)

Publication Number Publication Date
ATE449187T1 true ATE449187T1 (de) 2009-12-15

Family

ID=23211260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02794901T ATE449187T1 (de) 2001-08-16 2002-08-16 Molekulare eigenschaften von nichtkleinzelligem lungenkrebs

Country Status (8)

Country Link
US (2) US7332590B2 (de)
EP (1) EP1453977B1 (de)
JP (1) JP2005503145A (de)
AT (1) ATE449187T1 (de)
AU (1) AU2002355963A1 (de)
CA (1) CA2456334A1 (de)
DE (1) DE60234467D1 (de)
WO (1) WO2003015613A2 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2456334A1 (en) * 2001-08-16 2003-02-27 The United States Of America As Represented By The Secretary Department Of Health And Human Services Molecular characteristics of non-small cell lung cancer
ATE331044T1 (de) * 2003-03-04 2006-07-15 Pamgene Bv Verfahren zur integrierten integritätsbewertung und analyse von nukleinsäuren
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
KR101126560B1 (ko) * 2003-05-30 2012-04-05 도꾜 다이가꾸 약제 반응 예측 방법
EP2327796A1 (de) * 2003-06-10 2011-06-01 The Trustees Of Boston University Nachweismethoden für Lungenerkrankungen
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
JP2007507243A (ja) * 2003-10-03 2007-03-29 バイエル・フアーマシユーチカルズ・コーポレーシヨン 遺伝子発現プロファイルおよび使用方法
ATE496142T1 (de) 2004-03-23 2011-02-15 Oncotherapy Science Inc Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2006056080A1 (en) * 2004-11-29 2006-06-01 Diagnocure Inc. Gpx2 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis
EP3770278A1 (de) 2005-04-14 2021-01-27 The Trustees of Boston University Diagnose für lungenerkrankungen mittels klassenvorhersage
WO2007086915A2 (en) 2005-05-12 2007-08-02 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
KR100710462B1 (ko) 2005-08-24 2007-04-24 광주과학기술원 폐암 진단용 퍼옥시레독신-ｉ자가항체 마커 및 이를 이용한진단키트
WO2007081387A1 (en) 2006-01-11 2007-07-19 Raindance Technologies, Inc. Microfluidic devices, methods of use, and kits for performing diagnostics
EP2605018A1 (de) 2006-03-09 2013-06-19 The Trustees of the Boston University Diagnose- und Prognoseverfahren für Lungenerkrankungen mittels Genexpressionsprofilen aus Nasenepithelzellen
EP2047910B1 (de) 2006-05-11 2012-01-11 Raindance Technologies, Inc. Mikrofluidische Vorrichtung und Verfahren
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP3536396B1 (de) 2006-08-07 2022-03-30 The President and Fellows of Harvard College Fluorkohlenstoffemulsionsstabilisierende tenside
WO2008044957A1 (fr) * 2006-10-09 2008-04-17 Institut Molekulyarnoi Genetiki Rossiiskoi Akademii Nauk (Img Ran) Procédé d'analyse différentielle de protéomes
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20090186951A1 (en) 2007-09-19 2009-07-23 Brody Jerome S Identification of novel pathways for drug development for lung disease
US8211643B2 (en) 2008-05-14 2012-07-03 University Health Network Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
EP2145964A1 (de) * 2008-07-17 2010-01-20 Universität Zu Köln Verfahren zur Früherkennung und Prognose von Lungenkrebs
EP2315629B1 (de) 2008-07-18 2021-12-15 Bio-Rad Laboratories, Inc. Tröpfchenbibliotheken
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
WO2010099923A1 (en) 2009-03-04 2010-09-10 Roche Diagnostics Gmbh Serpin b 13 as a marker for squamous cell carcinoma of the lung
EP2411148B1 (de) 2009-03-23 2018-02-21 Raindance Technologies, Inc. Manipulation von mikrofluidiktröpfchen
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2493916B1 (de) * 2009-10-26 2016-06-08 Externautics S.p.A. Marker für lungentumore und deren verwendung
CA2780633C (en) 2009-11-13 2019-06-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
EP2517025B1 (de) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
WO2011100604A2 (en) 2010-02-12 2011-08-18 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
US9364803B2 (en) 2011-02-11 2016-06-14 Raindance Technologies, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
DE202012013668U1 (de) 2011-06-02 2019-04-18 Raindance Technologies, Inc. Enzymquantifizierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
EP3495817A1 (de) 2012-02-10 2019-06-12 Raindance Technologies, Inc. Molekulardiagnostischer screeningtest
EP2844768B1 (de) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digitale analyse von analyten
WO2014186036A1 (en) 2013-03-14 2014-11-20 Allegro Diagnostics Corp. Methods for evaluating copd status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
WO2014172288A2 (en) 2013-04-19 2014-10-23 Raindance Technologies, Inc. Digital analyte analysis
US20150087728A1 (en) * 2013-09-20 2015-03-26 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
WO2015117133A1 (en) 2014-02-03 2015-08-06 Integrated Diagnostics, Inc. Integrated quantification method for protein measurements in clinical proteomics
EP3770274A1 (de) 2014-11-05 2021-01-27 Veracyte, Inc. Systeme und verfahren zur diagnose von idiopathischer pulmonaler fibrose auf transbronchialen biopsien mit maschinellem lernen und hochdimensionalen transkriptionsdaten
CN105154542B (zh) * 2015-09-01 2018-04-17 杭州源清生物科技有限公司 一组用于肺癌分子分型的基因及其应用
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10927417B2 (en) 2016-07-08 2021-02-23 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
WO2020201362A2 (en) * 2019-04-02 2020-10-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting and preventing cancer in patients having premalignant lesions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4445990A (en) * 1981-11-12 1984-05-01 General Electric Company Electrolytic reactor for cleaning wastewater
US5763165A (en) * 1994-03-10 1998-06-09 Ludwig Institute For Cancer Research Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
WO1999050278A1 (en) * 1998-03-31 1999-10-07 Genzyme Corporation Compositions and methods for the identification of lung tumor cells
CA2328138A1 (en) * 1998-05-21 1999-11-25 Diadexus Llc A novel method of diagnosing, monitoring, and staging lung cancer
US20030065157A1 (en) * 2001-04-04 2003-04-03 Lasek Amy W. Genes expressed in lung cancer
CA2456334A1 (en) * 2001-08-16 2003-02-27 The United States Of America As Represented By The Secretary Department Of Health And Human Services Molecular characteristics of non-small cell lung cancer
US20060151337A1 (en) * 2005-01-07 2006-07-13 Gilmore F W Electrocoagulation Reaction Chamber

Also Published As

Publication number Publication date
EP1453977A2 (de) 2004-09-08
EP1453977B1 (de) 2009-11-18
US20090270265A1 (en) 2009-10-29
DE60234467D1 (de) 2009-12-31
JP2005503145A (ja) 2005-02-03
CA2456334A1 (en) 2003-02-27
US20050136403A1 (en) 2005-06-23
WO2003015613A3 (en) 2004-06-24
AU2002355963A1 (en) 2003-03-03
US7709202B2 (en) 2010-05-04
US7332590B2 (en) 2008-02-19
WO2003015613A2 (en) 2003-02-27
EP1453977A4 (de) 2005-04-20

Similar Documents

Publication Publication Date Title
ATE449187T1 (de) Molekulare eigenschaften von nichtkleinzelligem lungenkrebs
Wu et al. A single-cell and spatially resolved atlas of human breast cancers
Yanagisawa et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer
Newman et al. Robust enumeration of cell subsets from tissue expression profiles
Aran et al. Systematic pan-cancer analysis of tumour purity
Anglani et al. Loss of connectivity in cancer co-expression networks
Bittner et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling
Covell et al. Molecular classification of cancer: unsupervised self-organizing map analysis of gene expression microarray data
Morandi et al. CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel
Rahbari et al. Identification of differentially expressed microRNA in parathyroid tumors
Dao et al. Inferring cancer subnetwork markers using density-constrained biclustering
US7247426B2 (en) Classifying cancers
Zuidervaart et al. Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development
Feller et al. Hunting for the ultimate liquid cancer biopsy-let the TEP dance begin
CN109444425A (zh) 一种细胞水平蛋白高通量检测方法
Peng et al. Construction and validation of an immune infiltration-related gene signature for the prediction of prognosis and therapeutic response in breast cancer
Wei et al. Integrative analysis of biomarkers through machine learning identifies stemness features in colorectal cancer
Anjomshoaa et al. Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer
Menyailo et al. Heterogeneity of Circulating Epithelial Cells in Breast Cancer at Single‐Cell Resolution: Identifying Tumor and Hybrid Cells
Poornima et al. Genomic alphabets of saliva as a biomarker in oral cancer
Adam et al. The recurring features of molecular subtypes in distinct gastrointestinal malignancies—A systematic review
Becker et al. Clinical proteomics: new trends for protein microarrays
Mäkitie et al. Molecular profiling of laryngeal cancer
Rao et al. Laser capture microdissection: a gear for pancreatic cancer research
Fox et al. Altered expression of TFF-1 and CES-2 in Barrett's esophagus and associated adenocarcinomas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties